A sustained release cisapride oral dosage formulation suitable for once-daily administration comprises a plurality of mini-tablets containing cisapride or a salt thereof with an organic acid and capable or releasing cisapride at different sites along the gastrointestinal tract. The mini-tablets include a proportion of immediate release tablets and a proportion of tablets which release cisapride in response to the pH environment at a given site in the distal regions of the gastrointestinal tract and which include cisapride or a salt thereof embedded in a matrix of hydrophilic polymer, said matrix being coated with a pH dependent polymer, the formulation having a Cmax/Cmin ratio under steady state conditions of 2:1 or less as evidenced by a substantially flat plasma profile in vivo.
申请公布号
WO9829095(A2)
申请公布日期
1998.07.09
申请号
WO1997IE00084
申请日期
1997.12.12
申请人
ELAN CORPORATION, PLC;CLANCY, MAURICE, JOSEPH, ANTHONY;CUMMING, KENNETH, IAIN